New Drugs, New Tests and Stewardship are the Answer to AMR
Pharmaceutical Technology spoke with IDSA Spokesperson and Clinical Affairs Committee Chair Susan Bleasdale, M.D., FIDSA, on restoring the world’s antibiotic pipeline.
“Diseases such as sepsis are on the rise, and there is increased resistance to existing drugs,” Dr. Bleasdale said. “There is a need for better tracking of AMR and recording the data. The goal is to improve the pipeline and to require participation in stewardship programs,” she continued. “Improvements have been made in rapid diagnostics and research is ongoing into genetic markers for resistance.” In the end, when it comes to beating AMR, she said, “a combination of new drugs, new tests, and stewardship will be the answer."
This is just one of the news pieces that IDSA and our member spokespersons contributed to, in addition to others in the pipeline. Follow us on Twitter, LinkedIn and Facebook to see the latest news and opinion pieces featuring IDSA, HIVMA and our members.
- HealthDay: Houseflies: Just How Bad Are They for Your Health? (Amesh Adalja, M.D., FIDSA)
- Infectious Diseases in Children: Just 41% of eligible kids get MMR vaccine before travel outside US (Aaron Glatt, M.D., FIDSA)
- Infectious Disease News: PCR beneficial in diagnosing bone and joint infection (Angela Hewlett, M.D., FIDSA)
- Infectious Disease News: USPSTF: Counsel sexually active teens, adults at risk for STIs (Jeffrey Klausner, M.D.)
- Infectious Disease News: ‘Worthwhile to consider’: Does the world need a pentavalent flu vaccine? (Andy Pavia, M.D., FIDSA)
- Politico: How some — but not all — dating apps are taking on the STD epidemic (Jeffrey Klausner, M.D.)